FDA gives directive for re-exportation of all unregistered products by importers
In a decisive move to ensure public health and safety, the Food and Drugs Authority (FDA) has enforced a stringent importation policy mandating that only registered FDA-regulated products can be imported into the country. This regulation, effective immediately, is in accordance with Part 7, sections 97, 118, and 124 of the Public Health Act, Act 851 of 2012.
Under the new policy, importers are required to adhere to the guidelines and register their FDA-regulated products before initiating any importation activities. Failure to comply with these regulations may result in the denial of import permits or other necessary approvals.
The FDA have emphasized the importance of adhering to these guidelines to protect public health and maintain regulatory standards. Importers who have already brought in unregistered FDA-regulated products are urged to take immediate action to re-export these goods.
This stringent importation policy reflects the FDA’s commitment to ensuring that all products entering the country meet the necessary quality and safety requirements. By strictly enforcing the registration process, the FDA aims to enhance consumer protection and strengthen its overall regulatory framework.
The implementation of this policy reinforces the role of the regulatory authority in safeguarding public health and maintaining the integrity of Ghana’s importation system. Importers and stakeholders are advised to familiarize themselves with the regulatory requirements and promptly comply to avoid any disruptions to their import activities.
The Authority’s focus on stringent import regulations underscores its dedication to maintaining high standards and protecting the well-being of its citizens. By prioritizing the registration of FDA regulated products, the country aims to enhance the safety and quality of goods available within its borders.
